-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NXaLw4Mw10m5fRqzrmE7DCLOcKftpMdgqD2zBU3xsj94xtd3LlkXFlLSq/F7SHcZ jriJks+qOkseXRWlAqANyg== 0000950123-02-010023.txt : 20021029 0000950123-02-010023.hdr.sgml : 20021029 20021029115553 ACCESSION NUMBER: 0000950123-02-010023 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20021029 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: A L INDUSTRIER AS CENTRAL INDEX KEY: 0001034010 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: HARBITZALLEEN 3 STREET 2: SKOYAN OSLO NORWAY SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ALPHARMA INC CENTRAL INDEX KEY: 0000730469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222095212 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-35893 FILM NUMBER: 02800729 BUSINESS ADDRESS: STREET 1: ONE EXECUTIVE DR STREET 2: P O BOX 1399 CITY: FORT LEE STATE: NJ ZIP: 07024 BUSINESS PHONE: 2019477774 FORMER COMPANY: FORMER CONFORMED NAME: A L LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: A L PHARMA DATE OF NAME CHANGE: 19960513 SC 13D/A 1 y64932sc13dza.txt AMENDMENT NO. 10 TO SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 10) ALPHARMA INC. - -------------------------------------------------------------------------------- (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $.20 PER SHARE - -------------------------------------------------------------------------------- (Title of Class of Securities) 001629 10 4 - -------------------------------------------------------------------------------- (CUSIP Number) EINAR W. SISSENER C/O ALPHARMA INC. ONE EXECUTIVE DRIVE FORT LEE, NEW JERSEY 07024 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) OCTOBER 29, 2002 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. | | NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss.240.13d-7 for other parties to whom copies are to be sent. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 7 Pages - --------------------------- ------------------------ CUSIP No. 001629 10 4 13D Page 2 of 7 Pages - --------------------------- ------------------------ - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS / I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) A. L. Industrier ASA - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)|_| (b)|_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* 00, BK - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Norway - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES 11,872,897 -------------------------------- BENEFICIALLY 8 SHARED VOTING POWER OWNED BY -0- -------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON 11,872,897 -------------------------------- WITH 10 SHARED DISPOSITIVE POWER -0- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 11,872,897 - ----------- -------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* - ----------- -------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 23.16% - ----------- -------------------------------------------------------------------- TYPE OF REPORTING PERSON* CO - ----------- -------------------------------------------------------------------- * SEE INSTRUCTIONS. Page 2 of 7 Pages AMENDMENT NO. 10 TO STATEMENT ON SCHEDULE 13D Pursuant to Rule 13d-2(a) of Regulation 13D-G of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended (the "Act"), the undersigned ("Industrier") hereby files this Amendment No. 10 to its Schedule 13D Statement dated February 19, 1997 (as amended from time to time, the "Schedule 13D") relating to the Class A Common Stock, par value $.20 per share (the "Common Stock") of Alpharma Inc. (the "Issuer") to amend the items and schedules set forth herein and to file an exhibit. No amendment is made to the items or schedules not set forth below. Capitalized terms used but not otherwise defined herein have the meanings set forth in the Schedule 13D. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. As disclosed in the Schedule 13D and previous amendments thereto, Industrier has used funds borrowed from Den norske Bank ASA ("DnB") to purchase securities of the Issuer. Pursuant to the loan agreement dated August 13, 2001 by and between DnB and AL Chemy AS ("AL Chemy"), a wholly-owned subsidiary of Industrier, filed as Exhibit 1 to Amendment No. 6 to the Schedule 13D (the "Original Loan Agreement"), DnB provided AL Chemy with a loan of $100,000,000. The Original Loan Agreement was to have terminated on June 30, 2002, but was extended pursuant to letter agreements provided to AL Chemy and Industrier by DnB and filed as exhibits to Amendment Nos. 7, 8 and 9 to the Schedule 13D. On October 29, 2002, AL Chemy entered into a Loan Facility Agreement, filed as Exhibit 1 to this Amendment No. 10 to the Schedule 13D and incorporated herein by reference (the "New Loan Agreement"), with DnB and Gjensidige Nor Sparebank ASA (collectively, the "Banks"), pursuant to which the Banks agreed to lend up to $33,000,000 to AL Chemy. On November 1, 2002, AL Chemy will borrow $22,000,000 under the loan facility provided pursuant to the New Loan Agreement to repay all amounts outstanding under the loan provided pursuant to the Original Loan Agreement. Once this payment has been made, the Original Loan Agreement will be terminated. AL Chemy intends to borrow an additional $11,000,000 under the loan facility provided pursuant to the New Loan Agreement during the month of November. All amounts borrowed under the New Loan Agreement are due June 30, 2003. Industrier has provided a Guarantee, filed as Exhibit 2 to this Amendment No. 10 to the Schedule 13D and incorporated herein by reference (the "Guarantee"), to the Banks, pursuant to which Industrier has agreed to pay any amounts owed by AL Chemy under the New Loan Agreement which AL Chemy fails to pay punctually. Pursuant to the New Loan Agreement, the Banks have a security interest in all of Industrier's shares in AL Chemy and Wangs Fabrik AS ("Wangs Fabrik"), a wholly-owned subsidiary of Industrier. Industrier is the beneficial and record owner of all of the shares of AL Chemy and Wangs Fabrik. AL Chemy and Wangs Fabrik are the record holders of 10,599,459 shares of the Class B Stock beneficially owned by Industrier. Therefore, in certain cases upon the occurrence of an event of default under the New Loan Agreement, the Banks could become the beneficial owner of 10,599,459 shares of Class B Stock beneficially owned by Industrier. The New Loan Agreement provides that an event of default will occur upon (i) the failure of AL Chemy to make any payments due pursuant to the New Loan Agreement, (ii) the default by AL Chemy in performing its covenants under the New Loan Agreement and related documents, (iii) a material misrepresentation by AL Chemy pursuant to the New Loan Agreement or any notice, certificate or statement delivered pursuant thereto, (iv) any default by AL Chemy or Wangs Fabrik with respect to borrowed money or guarantee obligations, (v) the levying of a distress or other execution upon the assets of AL Chemy or Wangs Fabrik which is not discharged within 30 days, (vi) certain events of insolvency or bankruptcy of AL Chemy or Wangs Fabrik, (vii) the cessation of carrying on its business by, or the disposal of a substantial part of the assets of, AL Chemy or Wangs Fabrik, or a threat by AL Chemy or Wangs Fabrik to do either of the foregoing, (viii) the cessation of any security document delivered in connection with the New Loan Agreement to be in full force and effect, (ix) the revocation of any consents required for the performance of AL Chemy of its obligations under the New Loan Agreement or of Industrier of its obligations under the Page 3 of 7 Pages Guarantee, (x) any change in the ownership of Industrier so that the Sissener family no longer owns or controls at least 40% of the voting power of Industrier without the prior written consent of the Banks, (xi) the failure to maintain a certain level of equity to debt (which includes a computation based, in part, on the market value of the Common Stock), or (xii) the arising of a situation which, in the opinion of the Banks, will prevent the fulfillment by AL Chemy of its obligations under the New Loan Agreement or the fulfillment by Industrier of its obligations under the Guarantee. The events of default are further described in Section 13.1 of the New Loan Agreement, which is incorporated herein by reference. The information set forth in Items 4 and 5 of this Schedule 13D is hereby incorporated herein by reference. ITEM 4. PURPOSE OF TRANSACTION. The purpose of the transaction described in Item 3 above was to terminate the Original Loan Agreement and replace it with the New Loan Agreement. Subject to such actions as may be taken pursuant to the Issuer's Board of Directors in the normal course of carrying out its responsibilities (including pursuing a corporate strategy which includes seeking the acquisition of other businesses), Industrier has no plan or proposal that relates to or would result in: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) Any change in the present board of directors (except as may occur at the next annual meeting of the Issuer) or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the Issuer; (f) Any other material change in the Issuer's business or corporate structure; (g) Changes in the Issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) A class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or (j) Any action similar to any of those enumerated above. Page 4 of 7 Pages Nothing herein is intended to limit Industrier's right and ability to suggest to the Issuer a plan or proposal for any such action in the future and to exercise its voting rights in its discretion as holder of the Class B Stock of the Issuer to elect a majority of the Issuer's directors. The information set forth in Item 3 of this Schedule 13D is hereby incorporated herein by reference. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a) Industrier beneficially owns 11,872,897 shares of Common Stock which it may acquire upon conversion, on a share for share basis, of the Class B Stock which it beneficially owns. Such beneficial ownership constitutes approximately 23.16% of the outstanding Common Stock (assuming conversion of the Class B Stock and the issuance of no shares of Common Stock pursuant to any outstanding options or convertible securities of the Issuer). Pursuant to the New Loan Agreement, the Banks have a security interest in all of Industrier's shares in AL Chemy and Wangs Fabrik. Industrier is the beneficial and record owner of all of the shares of AL Chemy and Wangs Fabrik. AL Chemy and Wangs Fabrik are the record holders of 10,599,459 shares of the Class B Stock beneficially owned by Industrier. Therefore, in certain cases upon the occurrence of an event of default under the New Loan Agreement, the Banks could become the beneficial owner of 10,599,459 shares of Class B Stock beneficially owned by Industrier. The New Loan Agreement provides that an event of default will occur upon (i) the failure of AL Chemy to make any payments due pursuant to the New Loan Agreement, (ii) the default by AL Chemy in performing its covenants under the New Loan Agreement and related documents, (iii) a material misrepresentation by AL Chemy pursuant to the New Loan Agreement or any notice, certificate or statement delivered pursuant thereto, (iv) any default by AL Chemy or Wangs Fabrik with respect to borrowed money or guarantee obligations, (v) the levying of a distress or other execution upon the assets of AL Chemy or Wangs Fabrik which is not discharged within 30 days, (vi) certain events of insolvency or bankruptcy of AL Chemy or Wangs Fabrik, (vii) the cessation of carrying on its business by, or the disposal of a substantial part of the assets of, AL Chemy or Wangs Fabrik, or a threat by AL Chemy or Wangs Fabrik to do either of the foregoing, (viii) the cessation of any security document delivered in connection with the New Loan Agreement to be in full force and effect, (ix) the revocation of any consents required for the performance of AL Chemy of its obligations under the New Loan Agreement or of Industrier of its obligations under the Guarantee, (x) any change in the ownership of Industrier so that the Sissener family no longer owns or controls at least 40% of the voting power of Industrier without the prior written consent of the Banks, (xi) the failure to maintain a certain level of equity to debt (which includes a computation based, in part, on the market value of the Common Stock), or (xii) the arising of a situation which, in the opinion of the Banks, will prevent the fulfillment by AL Chemy of its obligations under the New Loan Agreement or the fulfillment by Industrier of its obligations under the Guarantee. The events of default are further described in Section 13.1 of the New Loan Agreement, which is incorporated herein by reference. Page 5 of 7 Pages (b) 8,226,562 of the shares of Common Stock beneficially owned by Industrier are held of record by Wangs Fabrik and 2,372,897 shares of Common Stock beneficially owned by Industrier are held of record by AL Chemy. However, Industrier possesses the sole power to direct voting and disposition of such shares. Sissener beneficially owns 373,667 shares of Common Stock and he possesses sole power to direct voting and disposition of the shares of Common Stock beneficially owned by him. (c) Except for the transactions described herein, there have been no other transactions in the securities of the Issuer effected by Industrier in the last 60 days. (d) No person other than Industrier or its wholly-owned subsidiaries has any right to receive or direct the receipt of dividends from, or the proceeds from any sale of, the shares of Class B Stock beneficially owned by Industrier or the Common Stock issuable upon conversion thereof. (e) Inapplicable. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER. Industrier is not a party or otherwise subject to any contract, arrangement, understanding or relationship with any person relating to any securities of the Issuer, except: (i) A Loan Facility Agreement dated October 29, 2001 by and among AL Chemy and the Banks filed as Exhibit 1 to this Amendment No. 10 to the Schedule 13D, the provisions of which are incorporated herein by reference; and (ii) A Guarantee dated October 29, 2002 by Industrier in favor of the Banks filed as Exhibit 2 to this Amendment No. 10 to the Schedule 13D, the provisions of which are incorporated herein by reference. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. Exhibit 1 - A Loan Facility Agreement dated October 29, 2001 by and among AL Chemy and the Banks filed as Exhibit 1 to this Amendment No. 10 to the Schedule 13D, the provisions of which are incorporated herein by reference. Exhibit 2 - A Guarantee dated October 29, 2002 by Industrier in favor of the Banks filed as Exhibit 2 to this Amendment No. 10 to the Schedule 13D, the provisions of which are incorporated herein by reference. Page 6 of 7 Pages SIGNATURES After reasonable inquiry and to the best of each of the undersigned's knowledge and belief, each of the undersigned certify that the information set forth in this statement is true, complete and correct. Date: October 29, 2002 A. L. INDUSTRIER ASA By: /s/ Einar W. Sissener --------------------- Name: Einar W. Sissener Its: Chairman Page 7 of 7 Pages EX-99.1 3 y64932exv99w1.txt LOAN FACILITY AGREEMENT Exhibit 1 USD 33,000,000 L O A N F A C I L I T Y A G R E E M E N T between A L C H E M Y A S as Borrower and D E N N O R S K E B A N K A S A and G J E N S I D I G E N O R S P A R E B A N K A S A as Banks and D E N N O R S K E B A N K A S A as Agent DATED 29 October 2002 -2- C O N T E N T S 1. DEFINITIONS 3 2. THE LOAN FACILITY 6 3. PURPOSE 7 4. CONDITIONS PRECEDENT 7 5. USD UNAVAILABILITY 8 6. INTEREST 9 7. REPAYMENT 10 8. PREPAYMENT 10 9. REPRESENTATIONS, UNDERTAKINGS AND SECURITY 11 10. CHANGES IN CIRCUMSTANCES 13 11. FEES AND EXPENSES 14 12. PAYMENTS 15 13. EVENTS OF DEFAULT 16 14. TRANSFER 18 15. AGENCY 18 16. NOTICES AND TIME 20 17. GOVERNING LAW AND JURISDICTION 21 EXHIBIT 1 BANK COMMITMENTS EXHIBIT 2 FORM OF DRAWDOWN NOTICE EXHIBIT 3 FORM OF RENEWAL NOTICE -3- This Loan Facility Agreement (the "AGREEMENT") is made on 29 October 2002 between: (1) AL CHEMY AS of Harbitzalleen 3, 0212 Oslo Foretaksregisteret NO 982 789 818 (the "BORROWER"); and (2) DEN NORSKE BANK ASA of Stranden 21, Oslo, Norway Foretaksregisteret NO 810 506 482, and GJENSIDIGE NOR SPAREBANK ASA of Kirkegaten 18, 0107 Oslo Foretaksregisteret NO 984 851 006 (the "BANKS"); and (3) DEN NORSKE BANK ASA of Stranden 21, Oslo, Norway (as the "AGENT"). 1. DEFINITIONS 1.1 As used in this Agreement and in any documents delivered pursuant hereto, the following expressions shall have the following meanings respectively: "BANKING DAY" means a day upon which banks are open for transactions contemplated by this Agreement in (a) Oslo and London, and (b) additionally in relation to payments hereunder the place for provision of funds or due payment; "COMMITMENT" means USD 33,000,000 (as the same may be reduced from time to time in compliance with Clause 2.5); "DRAWDOWN DATE" means a date upon which a Drawing is advanced to the Borrower; -4- "DRAWING" means an advance to the Borrower in an amount of not less than USD 3,000,000; "EVENT OF DEFAULT" means any of the events specified in Clause 13; "FACILITY" means the loan facility, the terms and conditions of which are set out in this Agreement; "GUARANTEE" means the unconditional and irrevocable guarantee by the Guarantor of all the Borrower's obligations under this Agreement; "GUARANTOR" means AL Industrier ASA, Foretaksregisteret NO 910 254 685; "INTEREST BEARING DEBT" means, for the purpose of this Agreement, any principal amount outstanding under this Facility; "INTEREST PAYMENT DATE" means the last day of each Interest Period; "INTEREST PERIOD" means a period calculated in accordance with the provisions of Clause 6.1 or Clause 12.2; "LIBOR" (London Interbank Offered Rate) means in relation to a Drawing and in respect of any Interest Period (a) the rate per annum equal to the offered quotation for deposits in amounts equal to that Drawing or the Loan (and for periods equal to the Interest Period of that Drawing or the Loan) ascertained by the Agent to be the rate established by the British Bankers' Association and appearing on Reuters page LIBOR 01, published by Reuters through its monitor service or any equivalent successor to such service at or about 11.00 a.m. (London time) on the applicable Quotation Date; or (b) if no such rate is available, the arithmetic mean of the rate per annum at which the Banks are able to acquire USD in the amount and for the Interest -5- Period equal to such Drawing in the London interbank market at or about 11.00 a.m. (London time) on the applicable Quotation Date, as (in the absence of manifest error) conclusively certified by the Agent to the Borrower; "LOAN" means the aggregate principal amount for the time being advanced being advanced and outstanding hereunder; "MARGIN" means 3 % p.a. as adjusted in accordance with Clause 6.4; "MONTH(S)" means a period calculated from any specified day to and including the day numerically corresponding to such specified day (or, if such specified day is the last day or if there shall be no day numerically corresponding to such specified day, the last day) in the relevant subsequent calendar month; "NOK" means the lawful currency of Norway; "QUOTATION DATE" means in relation to any Interest Period for which an interest rate is to be determined hereunder (a) the day on which quotations would ordinarily be given in the London interbank market for deposits in the currency in relation to which such rate is to be determined for delivery on the first day of that Interest Period, or (b) if such earlier day is not a Banking Day the preceding Banking Day; "RELATED PERSON" means, in relation to the Borrower, AS Wangs Fabrik, AL Finans AS, AS Nopal, Agrovekst AS and the Guarantor, any shareholder owning or otherwise controlling directly or indirectly 10% or more of any of them and additionally any relative (e.i. person related by blood or marriage) to such shareholder; -6- "REPAYMENT DATE" means 30 June 2003; "SECURITY DOCUMENTS" means the documents listed in Clause 9.3; "SISSENER-FAMILY" means Einar W. Sissener, his children, his grandchildren, the EWS Foundation and any company which is owned or otherwise controlled directly or indirectly by any of them; "TAXES" means any taxes, levies, duties, charges, fees, deductions and withholdings levied or imposed by any governmental or other taxing authority whatsoever; "TERM DATE" means 30 May 2003; "TRANCHE" means any part of the Loan drawn and outstanding under this Agreement being a specified amount and having a separate Interest Period; "USD" means the lawful currency of the United States of America being a specified amount and having a separate Interest Period; and "VALUE ADJUSTED EQUITY" means, in respect of the Borrower, AS Wangs Fabrik and the Guarantor on consolidated basis, the sum of (1) the value at any time of their aggregate shares of class B in Alpharma Inc., provided that the value of each share of class B shall be equal to the bid price at such time of one share of class A as noted on the New York Stock Exchange, (2) the consolidated operating result of the Nopal AS group for the latest 12 months multiplied by 10 and (3) the value of the property Harbitzalleen 3/5, such value at any time to be fixed at USD 5,000,000. -7- 2. THE LOAN FACILITY 2.1 The Banks shall participate in the Facility on a several basis with the respective percentages of the Commitment as listed in Exhibit 1 hereto. 2.2 No Bank shall have the amount of its participation increased or reduced as a result of the failure of any other Bank to provide the amount of its participation. 2.3 Upon satisfaction of the conditions set out in Clause 4, the Banks shall make the Commitment available to the Borrower during the period from the date hereof up to and including the Term Date. 2.4 Not more than 3 Drawings may be made hereunder. 2.5 The Borrower may cancel any undrawn amount of the Commitment in whole or in part by giving not less than 10 Banking Days irrevocable prior written notice of such cancellation to the Agent. Amounts cancelled may not be subsequently drawn. 3. PURPOSE 3.1 The Borrower shall apply the Commitment to (i) refinance existing debt and (ii) cover any possible tax liability incurred from the sale of the Guarantor's shares in Dynal Biotech ASA. 4. CONDITIONS PRECEDENT 4.1 A Drawing may be made on any Banking Day during the period from the date hereof up to and including the Term Date, provided: (a) the Agent shall have received not less than 5 Banking Days prior to the first proposed Drawdown Date the following in form and content satisfactory to it: (i) a counterpart of this Agreement duly signed on behalf of the Borrower; (ii) a company certificate evidencing that the Borrower is duly registered as a limited company and a copy of its articles of association; -8- (iii) a copy of the resolution of the board of directors of the Borrower approving the execution and performance by the Borrower of this Agreement and specifying the persons authorised to sign this Agreement on its behalf; (iv) the Security Documents; (v) a company certificate evidencing that the Guarantor is duly registered as a limited company and a copy of its articles of assosiation; (vi) a copy of the resolution of the board of directors of the Guarantor approving the execution and performance by the Guarantor of the Guarantee and the Security Documents and specifying the person(s) authorized to sign the Guarantee and the Security Documents on its behalf; (b) the Agent shall have received not later than 12:00 noon Oslo time on the fourth Banking Day prior to each proposed Drawdown Date an irrevocable written drawdown notice substantially in the form of Exhibit 2 attached hereto; and (c) the Agent shall not have received notice from any Bank prior to 11:00 a.m. London time on the Quotation Date prior to the Drawdown Date that it is unable to obtain deposits in USD in the London interbank market in a sum necessary to fund its participation in the Loan. 4.2 The Agent may, in its discretion, require any copy document to be certified as a true copy. 4.3 The Agent shall promptly notify each Bank of any notice received pursuant to Clause 4.1 (b) or (c) and of compliance with Clause 4.1 (a), and shall promptly notify the Borrower of any notice received pursuant to Clause 4.1 (c). 5. USD UNAVAILABILITY 5.1 In the event that on any Quotation Date the Banks are unable to obtain deposits in USD in the London interbank market to fund a Drawing or the Loan, the Agent shall forthwith notify the Borrower and until such notice is withdrawn the obligations of the Banks to -9- advance any Drawing shall be suspended. The Banks shall endeavour to fund the Drawing or the Loan with USD from such other sources as may be available to them and in such event the rate of interest payable on such amount shall be the aggregate of the Margin and such rate as the Banks may from time to time certify as being the cost to them of funds in USD. 5.2 In the event that the Banks are unable to fund such amount from alternative sources, the Agent shall forthwith notify the Borrower and the Borrower shall repay such amount on the earlier of the next following Interest Payment Date and the date falling 5 Banking Days after receipt of such notice. In the event that the Banks are able to fund such amount from alternative sources but the Borrower considers the interest rate so determined to be too high, it may prepay such amount on giving the Agent not less than 7 Banking Days' irrevocable written notice. If at any time when the Banks are funding the Drawing or the Loan from alternative sources the Agent determines, pursuant to an understanding to that effect between the Banks, that USD deposits are available to them in the London interbank market the Agent shall forthwith notify the Borrower and the rate of interest payable on such amount for the period from the expiry of the then current period for funding from alternative sources to the expiry of the then current Interest Period determined under Clause 6.1 shall be the aggregate of the Margin and such rate as the Agent may certify as the rate at which the Banks are able to obtain deposits for such period as aforesaid. 6. INTEREST 6.1 Each Interest Period shall begin on the Drawdown Date or, as the case may be, on the Interest Payment Date in respect of the preceding Interest Period and shall end on such date 1, 3 or 6 months thereafter as the Borrower may elect, subject to availability, by not less than 4 Banking Days' prior written notice to the Agent, provided that: (a) if any Interest Period would otherwise end on a day which is not a Banking Day it shall be extended to end on the succeeding Banking Day unless it would thereby end in a new calendar month in which event it shall be shortened to end on the preceding Banking Day; (b) subject to paragraph (c) below if no election is made by the Borrower in respect of any Interest Period, the length of such Interest Period shall be 3 months; -10- (c) if any Interest Period determined pursuant to the foregoing provisions would extend beyond the Repayment Date such Interest Period shall be shortened to end on the Repayment Date; (d) the availability of 1 month Interest Periods shall be limited to 3 times during the term of the Loan. 6.2 The Borrower shall pay interest on the Loan or the relevant Tranche in arrears on each Interest Payment Date and additionally in the case of an Interest Period exceeding 3 months duration at three-monthly intervals during such Interest Period at the annual rate which is conclusively certified by the Agent to be the aggregate of the Margin and LIBOR. 6.3 The Agent shall give notice to the Borrower and each Bank of each interest rate fixed on the Quotation Date for the relevant Interest Period, which notice shall, in the absence of manifest error, be conclusive. 6.4 The Margin shall be subject to adjustment proportionate to the adjustment of the margin under the USD 900,000,000 syndicated credit facility to Alpharma Inc. dated 5 October 2001 as later amended in accordance with the terms set out thereunder. Any adjustment of the Margin hereunder shall take place simultaneously with the adjustment of the margin being effected under the syndicated facility as aforesaid. 7. REPAYMENT 7.1 The Borrower shall repay the Loan together with all amounts outstanding hereunder on the Repayment Date. 8. PREPAYMENT 8.1 The Borrower may prepay the Loan without penalty in whole or in part on any Interest Payment Date subject to the Agent having received not less than 5 Banking Days prior to such date irrevocable written notice of the amount to be prepaid. 8.2 Any sum prepaid may not be redrawn by the Borrower. -11- 9. REPRESENTATIONS, UNDERTAKINGS AND SECURITY 9.1 The Borrower represents to the Agent and the Banks that: (a) it is duly formed and validly existing under the laws of Norway and has the power and has obtained all necessary consents for the execution and performance of this Agreement and the Security Documents to which it is a party; (b) this Agreement constitutes and those of the Security Documents to which it is a party will upon execution constitute valid, binding and enforceable obligations of the Borrower, and the execution and performance of this Agreement and such Security Documents do not and will not contravene any applicable law, order, regulation or restriction of any kind, including contractual restrictions, binding on the Borrower; (c) it is not in default under any other agreement to which it is a party, nor is it in default in respect of any financial commitment or obligation; (d) it has no other borrowings or guarantee liabilities except as disclosed to the Banks as of the date hereof ; and (e) it has provided the Guarantor with all material information relating to this Agreement and the Security Documents, including the content of Clause 13. 9.2 The Borrower undertakes to the Agent and the Banks that so long as any amount is outstanding hereunder: (a) it will promptly inform the Agent on behalf of the Banks of any occurrence of which it becomes aware which in its reasonable opinion might adversely affect its ability to perform its obligations hereunder or under any Security Document or constitute an Event of Default; (b) it will deliver to the Agent for distribution to the Banks copies of (i) its annual audited accounts not later than 150 days after the end of its financial year (ii) an unaudited quarterly report including balance sheet and profit and loss statement within 50 days after the end of each calendar quarter and (iii) such other financial or other information as the Agent may reasonably request; -12- (c) it will not, and will procure that AS Wangs Fabrik and the Guarantor shall not, make any further borrowings, enter into any guarantee liabilities or make any further investments without the prior written consent of the Agent on behalf of the Banks; (d) it will not, and will procure that AS Wangs Fabrik and the Guarantor shall not, create, incur or allow to exist over any of its assets any further mortgage, charge, pledge or lien other than those mentioned in Clause 9.3 without the prior written consent of the Agent on behalf of the Banks; (e) it will not, and will procure that AS Wangs Fabrik and the Guarantor shall not, make any payment of dividend or any other form of financial distribution to any of its owners or any subsidiaries or associated companies without the prior written consent of the Agent on behalf of the Banks, provided however that the payment of interest which is due and payable under any intra group loan shall, for the purpose of this Clause 9.2 (e), not be considered to be a financial distribution; (f) it will procure that there will be no change in ownership of it or of AS Wangs Fabrik, and that neither of them will be party to any merger, consolidation or similar action, without the prior written consent of the Agent on behalf of the Banks; (g) it will not, and will procure that AS Wangs Fabrik, AL Finans AS, AS Nopal, Agrovekst AS and the Guarantor shall not, enter into any agreement or effect any material transaction with a Related Person except on sound commercial terms which shall be approved by the Agent on behalf of the Banks; (h) it will not, and will procure that AS Wangs Fabrik and the Guarantor shall not, repay any intra-group loan or credit without first having repaid all outstanding debt to the Banks hereunder and any intra-group debt of the Borrower shall be subordinate to ordinary creditors; (i) it will not, and will procure that AS Wangs Fabrik, AL Finans AS, AS Nopal, Agrovekst AS and the Guarantor shall not, without the prior written consent of the Agent on behalf of the Banks, sell, transfer or otherwise dispose of any assets, except for transactions effected in the ordinary course of business. The same shall apply to any company which pursuant to the Norwegian -13- Limited Liability Companies Act section 1-3 is a subsidiary of any of the aforementioned companies, exclusive, however, of Alpharma Inc. The Agent on behalf of the Banks may require as a condition for granting such consent that all proceeds from any such sale, transfer or other kind of disposal of assets be applied against the drawn and outstanding amount hereunder, provided always that the proceeds of any sale, transfer of other kind of disposal by AS Nopal of any of its assets shall be applied firstly against any outstanding debt to Gjensidige NOR Sparebank ASA and secondly against the Loan outstanding hereunder. 9.3 The Loan, and all amounts outstanding hereunder, shall be secured by the following in form and content satisfactory to the Agent: (a) a first priority pledge of all the Guarantor's shares in AS Nopal, AS Wangs Fabrik, AL Finans AS and the Borrower; (b) a mortgage over the Guarantor's property Harbitzalleen 3/5, gnr. 31 bnr. 60 and 161 in Oslo, amounting to NOK 300,000,000, ranking in priority subject to a lease agreement between the Guarantor as lessor and Alpharma AS as lessee dated 28 September 1994; (c) the Guarantee. 10. CHANGES IN CIRCUMSTANCES 10.1 If by reason of: (i) changes in any existing law, rule or regulation, or (ii) the adoption of any new law, rule or regulation, or (iii) any change in the interpretation or administration of (i) or (ii) above by any governmental authority, or (iv) compliance with any directive or request from any governmental authority (whether or not having the force of law): (a) any of the Banks incurs a cost as a result of it having entered into this Agreement and/or performing its obligations hereunder; or (b) there is an increase in the cost to any of the Banks of maintaining or funding its portion of the Commitment, the Loan or any advances hereunder; or (c) any of the Banks becomes liable for any new taxes (other than on net income) calculated by reference to the Commitment or the Loan; or (d) any of the Banks becomes subject to any new or modified capital adequacy or similar requirements which will have the effect of increasing the amount of -14- capital required or expected to be maintained by such Bank based on such Bank's obligations hereunder; or (e) any of the Banks' effective return hereunder is reduced in any other manner; THEN any such cost, liability or reduction of return as referred to in the preceding paragraphs (a)-(e) shall be payable by the Borrower upon request by the Agent either in the form of an increased margin or in the form of an indemnification. The relevant Bank shall via the Agent give the Borrower notice within a reasonable time of its intention to claim compensation under this Clause 10.1 and it shall specify the form and amount of such compensation. The relevant Bank's determination of the amount of compensation to be made under this Clause 10.1 shall, absent manifest error, be conclusive. The Borrower shall be entitled to prepay such Bank's portion of the Loan in accordance with Clause 8 at any time following receipt of notice from the Agent as aforesaid on giving not less than 7 Banking Days' irrevocable written notice. In such event the Borrower shall nevertheless compensate such Bank for such requested indemnification for the period up to and including the date of prepayment. 10.2 In the event that it shall be unlawful for any Bank to make available its portion of the Commitment or maintain or fund its portion of the Loan hereunder then such Bank's obligations shall terminate and all amounts owing by the Borrower to such Bank shall become due and payable on demand by such Bank through the Agent. 10.3 Neither the Agent nor any Bank shall be liable for any failure to perform the whole or any part of this Agreement resulting directly or indirectly from the action or inaction or purported action of any government or other authority or any strike, lockout, boycott, blockade, or war affecting the Bank. 10.4 If at any time any provision of this Agreement is or becomes illegal, invalid or unenforceable in any respect under the laws of any jurisdiction, neither the legality, validity or enforceability of the remaining provisions hereof nor the legality, validity or enforceability of such provision under the laws of any other jurisdiction shall in any way be affected or impaired thereby. 11. FEES AND EXPENSES 11.1 The Borrower shall pay to the Agent: -15- (a) for the account of the Banks (i) on the date of the Borrower's acceptance of the term sheet as presented by the Banks prior to this Agreement, an arrangement fee of 0.5 % flat of the Commitment and (ii) on the first Drawdown Date, or if earlier, the date falling 5 Banking Days after the date hereof, an arrangement fee of 0.5 % flat of the Commitment; (b) for the account of the Banks, a commitment fee in respect of the undrawn part of the Commitment for the period from 1 December 2002 up to and including the earlier of the date the Commitment is fully utilised and the Term Date, of 50% of the applicable Margin at any time, calculated on the daily average undrawn amount of the Commitment, such fee to be payable quarterly in arrears first time 28 February 2003 and finally on the last day of such period as aforesaid; (c) upon demand, all expenses (including internal and external legal and collateral fees of the Agent) incurred by the Agent in connection with the preparation, execution or termination of this Agreement and any other documents delivered pursuant to this Agreement or incurred by the Agent and the Banks in connection with the preservation or enforcement of any rights hereunder and/or thereunder. 11.2 The obligations of the Borrower in Clause 11.1 (c) above shall survive the final Repayment Date. 12. PAYMENTS 12.1 In the event that the date on which a payment is due to be made hereunder is not a Banking Day, such date of payment shall be the following Banking Day unless it would thereby fall in a new calendar month in which event it shall be the preceding Banking Day. 12.2 In the event that any payment to be made hereunder by the Borrower to any Bank is not received by the Agent on the due date therefor, interest will be charged by such Bank from the due date until the date that payment is received at a rate which is equal to the aggregate of (i) the Margin (ii) a default funding charge of 3% per annum and (iii) the rate at which deposits from one Banking Day to the next in an amount approximately equal to the defaulted amount due to such Bank are offered to such Bank in the London interbank market at approximately 11:00 a.m. London time on the due date for payment -16- and on each succeeding Banking Day until payment in full of the amount due is received by such Bank; provided that if the Agent determines that such default may be reasonably expected to continue unremedied for a period exceeding one week then it may require by notice to the Borrower that the funding cost shall be determined by reference to the rate at which deposits are offered as aforesaid for periods of such length (not exceeding three months) as it may designate. Interest charged under this Clause 12.2 shall be payable on demand and unless so paid shall be added to the defaulted amount at the end of each month following the due date for payment of such amount. 12.3 All payments to be made by the Borrower hereunder shall be made without set-off or counterclaim. 12.4 All payments to be made by the Borrower hereunder shall be made free and clear of and without deduction for or on account of any present or future Taxes of any nature now or hereafter imposed unless the Borrower is compelled by law to make payment subject to any such Taxes. In that event the Borrower shall (i) pay to the Agent for account of the Banks such additional amounts as may be necessary to ensure that the Banks receive a net amount equal to that which they would have received had such payment not been made subject to any Taxes, and (ii) deliver to the Agent within 10 Banking Days of any request by it an official receipt in respect of the payment of any Taxes so deducted. 12.5 If any amount of principal is, for any reason whatsoever, repaid on a day other than the last day of the then current Interest Period relating to such amount, the Borrower shall pay to the Agent for account of the Banks on request such amount as may be necessary to compensate the Banks for any loss or premium or penalty incurred by them in respect of the liquidation or re-employment of funds borrowed for the purpose of maintaining the amount repaid. 12.6 If the Agent pays any amount to a Bank or the Borrower which has not but ought to have been paid to it by the Borrower or a Bank (as the case may be) then unless such amount is paid within 3 Banking Days of the due date such Bank or the Borrower (as the case may be) shall refund such amount to the Agent on demand. At the time such amount is paid or refunded the person paying the same shall also pay interest to the Agent on such amount at such rate per annum as reflects the cost to the Agent of funding such amount during the period from the time when such amount ought to have -17- been paid to the time when such amount was actually paid, provided, however, that this shall not reduce the obligations of the Borrower according to Clause 12.2 above. 12.7 Interest, commitment fee and any other payments hereunder of an annual nature shall accrue from day to day and be calculated on the actual number of days elapsed and on the basis of a 360 day year or of a 365 day year in the case of GBP and BEF or in any case where market practice differs, in accordance with market practice. 13. EVENTS OF DEFAULT 13.1 The obligations of the Banks hereunder shall terminate forthwith and any amount outstanding shall become immediately due and payable together with interest thereon and the Banks may exchange all or part of any outstanding amounts hereunder to NOK and/or enforce their rights under this Agreement and the Security Documents in the manner and order they deem appropriate, if any of the following events occurs and the Agent, upon the instruction of the Banks, gives notice to the Borrower: (a) if the Borrower fails to pay any sum due hereunder on the due date unless such failure results from technical error in which case a remedy period of three Banking Days shall apply; or (b) if the Borrower defaults in the due performance or observance of any term or covenant contained herein or in any Security Document and in the event that such default, in the reasonable opinion of the Banks is capable of remedy, continues unremedied for a period of 10 Banking Days after the Agent has given to the Borrower notice of such default; or (c) if any material representation made by the Borrower in this Agreement or in any notice, certificate or statement delivered or made pursuant hereto proves to have been inaccurate or misleading when made; or (d) if any indebtedness in respect of borrowed money or guarantee liabilities of the Borrower is not paid when due or becomes due prior to the specified payment date by reason of default; or (e) if a distress or other execution is levied upon or against any substantial part of the assets of the Borrower and is not discharged within 30 days; or -18- (f) if the Borrower is unable or admits in writing its inability to pay its lawful debts as they mature, or makes a general assignment for the benefit of its creditors; or (g) if any proceedings are commenced in or any order or judgment is given by any court for the liquidation, winding-up or reorganisation of the Borrower or for the appointment of a receiver, trustee or liquidator of the Borrower or all or any part of its assets (save for the purpose of amalgamation or reorganisation not involving insolvency, the terms of which shall have received the prior written approval of the Agent on behalf of the Banks); or (h) if the Borrower ceases or threatens to cease to carry on its business or disposes or threatens to dispose of a substantial part of its assets or the same are seized or appropriated for any reason; or (i) if any Security Document ceases to be in full force and effect; or (j) if any consent required for the performance by the Borrower of its obligations hereunder or by the Guarantor of its obligations under the Guarantee is revoked or is otherwise modified in a manner unacceptable to the Agent; or (k) if there is any change of the present ownership situation in the Guarantor so that the Sissener-family no longer owns or through agreement or otherwise controls 40 % or more of the voting power of the Guarantor, without the prior written approval of the Agent on behalf of the Banks; or (l) if the ratio, which shall be reported by the Borrower to the Agent quarterly within 60 days after the end of each calendar quarter and additionally, in respect of each year end, within 90 days after the end of each calendar year, of Value Adjusted Equity/Interest Bearing Debt at any time hereunder falls below 2,5; or (m) if a situation arises which, in the opinion of the Banks, after consultation with the Borrower, will prevent fulfilment by the Borrower of its obligations hereunder or by the Guarantor of its obligations under the Guarantee. 13.2 Clause 13.1 (d) - (h) shall also apply with respect to the Guarantor and AS Wangs Fabrik. -19- 14. TRANSFER 14.1 Any Bank may transfer all or part of its participation in the Facility to any other bank or financial institution by giving not less than 10 Banking Days' prior written notice to the Agent, which shall promptly notify the Borrower. Any transfer shall require the prior written consent of the Borrower, such consent not to be unreasonably withheld. In event of transfer references herein to such Bank shall be construed as references to its transferee or transferees to the extent necessary. 15. AGENCY 15.1 Each Bank authorises the Agent to take such action on its behalf and to exercise such powers as are specifically delegated to it by the terms hereof together with all such powers as are reasonably incidental thereto. The relationship between the Agent and each Bank is that of agent and principal only, and nothing herein shall impose on the Agent any duties or obligations other than those for which express provision is made herein. 15.2 Except as expressly provided herein the Agent shall distribute promptly to the Banks all sums received from the Borrower rateably in proportion to the amount of each Bank's participation in the Facility. 15.3 The Agent will promptly advise each Bank of any notice received by it from the Borrower hereunder and any material fact or circumstance of which it has actual knowledge. The Agent shall not be under any obligation towards any Bank to ascertain or enquire as to the performance or observance of any of the terms or conditions hereof or of the Security Documents to be performed or observed by any other party hereto or thereto. 15.4 Each Bank shall indemnify, to the extent not reimbursed by the Borrower, the Agent rateably according to the amount of its participation in the Facility against any loss, expenses (including legal fees) or liability (except such as results from the Agent's own gross negligence or wilful misconduct), which the Agent may suffer or incur in connection with the implementation, administration or enforcement of this Agreement or any Security Document. 15.5 In performing its duties and exercising its powers hereunder the Agent will be entitled to rely on (i) any communication believed by it to be genuine and to have been sent or -20- signed by the person by whom it purports to have been sent and signed and (ii) the opinions and statements of any professional advisers selected by it in connection herewith, and the Agent shall not be liable to any other party hereto for any consequence of any such reliance. 15.6 The Agent takes no responsibility for the truth of any representations made herein nor for the adequacy or enforceability of this Agreement and neither the Agent (except in the case of gross negligence or wilful misconduct) nor any of its directors, officers or employees shall be liable for any action taken or omitted by it or any of them. 15.7 Notwithstanding the agency hereinbefore constituted, the Agent may without liability to account therefore make loans to, accept deposits from and generally engage in any kind of banking or other business with the Borrower. The Agent and each Bank shall have the right (but no obligation) to set-off the total amount due hereunder from the Borrower to the Agent and the Banks against any claim the Borrower has against the Agent or such Bank (including any amount standing to the credit of any bank account), irrespective of such claims being nominated in different currencies. If any Bank shall at any time receive payment (whether by set-off, counterclaim or otherwise) and the result thereof is that it receives an amount which is greater in proportion to its participation than the amount received by any other Bank in proportion to such Bank's participation, then the receiving Bank shall, through the Agent, distribute such payment among the Banks in proportion to their pro rata participations in the Loan. 15.8 Each Bank acknowledges that it has taken and will take such independent action and make such investigations as it deems necessary to inform itself as to the financial condition and affairs of the Borrower. Each Bank shall be responsible for making its own assessment of the financial condition and affairs of the Borrower in connection with the making and continuance of the Loan and has made its own appraisal of the creditworthiness of the Borrower. 15.9 The Agent may grant waivers and consents, vary the terms of this Agreement and do or omit to do all such acts and things in connection with this Agreement as may be authorised in writing by the Banks. Any such waiver, consent, variation, act or omission so authorised and effected by the Agent shall be binding on the Banks, and the Agent shall be under no liability whatsoever in respect thereof. 15.10 The Agent may resign (without reason) its appointment at any time by giving a 30 days' prior written notice to the parties hereto. The resignation shall only become effective -21- upon the appointment of a new agent. The Agent may appoint a new agent among any reputable and experienced finance institution. Upon the appointment of a new agent, such new agent shall assume all rights and obligations from such time designated by the Agent, and the Agent shall from such time be discharged from any further obligations hereunder. 16. NOTICES AND TIME 16.1 Every notice under this Agreement shall be in writing and may be given or made by letter or telefax. Communications hereunder shall be addressed as follows:- (a) if to the Agent, at Stranden 21, 0021 Oslo telefax no. 22 48 10 46 Attention: Credit Administration; (b) if to the Borrower, at Harbitzalleen 3, 0212 Oslo telefax no. 22 52 91 50 Attention: Sverre Bjertnes; (c) if to the Banks, at their respective addresses listed in Exhibit 1 hereto; or to such other address as one party may hereafter notify to the other parties. 16.2 Communications sent by letter or telefax shall be effective upon receipt. Any communication by telefax from the Borrower to the Agent shall be confirmed by letter if so requested by the Agent. 16.3 No failure or delay on the part of the Agent or the Banks to exercise any power or right under this Agreement or the Security Documents shall operate as a waiver thereof or of any other power or right. The remedies provided herein are cumulative and are not exclusive of any remedies provided by law. 17. GOVERNING LAW AND JURISDICTION 17.1 This Agreement shall be governed by and construed in accordance with Norwegian law. 17.2 The Borrower hereby irrevocably submits to the non-exclusive jurisdiction of the Norwegian courts, the venue to be elected by the Agent. -22- The Borrower AL CHEMY AS By ...................................................................... Name in block letters ................................................... Title ................................................................... The Banks p.p. DEN NORSKE BANK ASA By ...................................................................... Name in block letters ................................................... Title ................................................................... p.p. GJENSIDIGE NOR SPAREBANK ASA By ...................................................................... Name in block letters ................................................... Title ................................................................... The Agent p.p. DEN NORSKE BANK ASA By ...................................................................... Name in block letters ................................................... Title ................................................................... -23- EXHIBIT 1 B A N K C O M M I T M E N T S Den norske Bank ASA 83.35% Stranden 21 0021 Oslo Telefax: 22 48 10 46 Attn: Credit Administration Gjensidige NOR Sparebank ASA 16.65% Kirkegaten 18 0107 Oslo Telefax: 22 31 86 43 Attn: Loan Administration ------ 100% -24- EXHIBIT 2 F O R M O F D R A W D O W N N O T I C E From: AL Chemy AS To: Den norske Bank ASA Attention: Credit Administration Date: ........................................... Dear Sirs We refer to a Loan Facility Agreement dated 29 October 2002 (the "Agreement") made between inter alia ourselves as Borrower and Den norske Bank ASA as Agent. Terms defined in the Agreement shall have the same meaning in this notice. We hereby give you irrevocable notice that pursuant to the Agreement and on .... ....................... 20...., we wish to draw down the amount of USD....................................... upon the terms and subject to the conditions contained therein. The Interest Period for the Drawing shall, subject to the provisions of the Agreement, be of ...... months duration. The Drawing, net of applicable fees and expenses described in Clause 11, shall be transferred to the account of .............................. with ............................................. , account no. ................................... . As of today no event has occurred which with or without notice and/or lapse of time would constitute an Event of Default under the Agreement. In the event that drawdown does not take place on the aforementioned date, by reasons beyond the control of the Agent and/or the Banks, we hereby undertake to reimburse you as Agent and all the Banks for any and all costs incurred, including but not limited to interest. Yours faithfully for and on behalf of ................................................................. ................................................................. (authorised officer) -25- EXHIBIT 3 F O R M O F R E N E W A L N O T I C E From: AL Chemy AS To: Den norske Bank ASA Attention: Credit Administration Date: ............................. Dear Sirs We refer to the Loan Facility Agreement dated 29 October 2002 (the "Agreement") and made inter alia between ourselves as Borrower and Den norske Bank ASA as Agent. Terms defined in the Agreement shall have the same meaning in this notice. The Interest Period for the relevant Tranche commencing on (date of renewal) shall, subject as provided in the Agreement, be of ( .......................) months duration. We confirm that at and as of the date hereof the representations set out in Clause 9 of the Agreement are true and that no event which is or may become (with the passage of time or the giving of notice or both) one of those events specified in Clause 13 of the Agreement has occurred. Oslo, .... ................................. 20.... for and on behalf of ................................................................. ................................................................. (authorised officer) EX-99.2 4 y64932exv99w2.txt GUARANTEE Exhibit 2 G U A R A N T E E 1. GUARANTEE AL INDUSTRIER ASA of Harbitzalleen 3, 0212 Oslo (the "GUARANTOR") hereby irrevocably and unconditionally guarantee to DEN NORSKE BANK ASA of Stranden 21, Oslo, Foretaksregisteret NO 810 506 482 and GJENSIDIGE NOR SPAREBANK ASA of Kirkegaten 18, 0107 Oslo, Foretaksregisteret NO 984 851 006 (together the "BANKS") as primary obligor the due and punctual payment of all sums payable now or in the future to the Banks by AL Chemy AS (the "BORROWER") pursuant to a USD 33,000,000 Loan Facility Agreement dated the date hereof (including any renewal or prolongation thereof) (the "LOAN AGREEMENT") between the Borrower, the Banks and Den norske Bank ASA as Agent, as and when such sums shall become due and payable (whether by acceleration or at stated maturity). 2. PAYMENT In the case of failure by the Borrower punctually to pay any sum due under the Loan Agreement (whether by acceleration or at stated maturity), the Guarantor hereby agrees to make such payment within 5 Banking Days of receipt of notice from the Agent. 3. DURATION This Guarantee is a continuing guarantee and shall remain in force until all sums which may be or become payable by the Borrower under the Loan Agreement have been paid in full. The Norwegian Financial Agreements Act section 67, sub-section four, shall not apply. 4. NATURE OF OBLIGATION The obligations of the Guarantor hereunder shall not be affected by any act, omission, or other matter which but for this provision might operate to release or otherwise exonerate the Guarantor from its obligations hereunder or affect such obligations including, without limitation and whether or not known to the Guarantor or the Banks: (i) any time or indulgence granted to, or composition with, the Borrower or any other person; -2- (ii) the taking, variation, compromise, renewal or release of, or refusal or neglect to perfect or enforce, any rights, remedies or securities against the Borrower or any other person; (iii) any legal limitation or other circumstances relating to the Borrower; (iv) any unenforceability or invalidity of any obligations of the Borrower or any other person under the Loan Agreement; (v) any omission to notify the Guarantor of any default under the Loan Agreement or any other fact or circumstance. 5. CLAIM AGAINST BORROWER The Guarantor shall not, until all the Borrower's liabilities under the Loan Agreement have been fully performed or satisfied (i) demand payment from the Borrower of amounts paid hereunder without the written consent of the Banks or (ii) prove in the liquidation or insolvency of the Borrower without the written consent of the Banks in respect of any monies paid or payable or contingently payable by the Guarantor under this Guarantee, and if such consent is given shall give the Banks the benefit of every such proof and all monies to be received in respect thereof. 6. OTHER SECURITY The Guarantor shall not be entitled to require the Banks first to proceed against or enforce any other guarantee or any security of, or claim payment from, the Borrower or any other person. 7. REPRESENTATIONS The Guarantor represents to the Banks that it is duly formed and validly existing under the laws of Norway and that this Guarantee constitutes valid, binding and enforceable obligations of the Guarantor. 8. PREVIOUSLY INCURRED OBLIGATIONS The obligations of the Borrower covered by this Guarantee comprise liabilities incurred prior to the issuance hereof. -3- 9. TAXES All payments of principal, interest or any other amounts payable hereunder, shall be made without set off or counterclaim and free and clear of and without deduction or withholding for any taxes or charges whatsoever. In the event any such deduction or withholding is required by law, the Guarantor shall pay such additional amount as will result in the Banks receiving the full amount due to it hereunder. 10. ASSIGNMENT This Guarantee may be assigned in connection with an assignment effected by any Bank pursuant to the terms and conditions of the Loan Agreement. Suchs assignment shall not require the consent of the Guarantor. 11. GOVERNING LAW This Guarantee shall be governed by and construed in accordance with Norwegian law. 29 October 2002 AL INDUSTRIER ASA By ................................................................. In block letters ................................................... -----END PRIVACY-ENHANCED MESSAGE-----